Edition:
United Kingdom

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.03USD
18 May 2018
Change (% chg)

$0.00 (+0.96%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.03
Volume
3,776,789
Avg. Vol
8,711,676
52-wk High
$1.88
52-wk Low
$0.03

Chart for

About

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment... (more)

Overall

Beta: 2.82
Market Cap(Mil.): $154.31
Shares Outstanding(Mil.): 78.91
Dividend: --
Yield (%): --

Financials

  NVCN.OQ Industry Sector
P/E (TTM): -- 148.43 32.75
EPS (TTM): -0.08 -- --
ROI: -- 9.37 14.38
ROE: -- 14.69 16.07

BRIEF-Neovasc Receives German Nub Status 1 Designation For Neovasc Reducer Procedure

* NEOVASC ANNOUNCES RECEIPT OF GERMAN NUB STATUS 1 DESIGNATION FOR NEOVASC REDUCER™ PROCEDURE FOR TREATMENT OF REFRACTORY ANGINA Source text for Eikon: Further company coverage:

01 Feb 2018

BRIEF-Fred Colen Appointed CEO Of Neovasc Inc

* FRED COLEN APPOINTED CHIEF EXECUTIVE OFFICER OF NEOVASC INC.

22 Jan 2018

BRIEF-Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc

* CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING Source text : [http://bit.ly/2kZxgLY] Further company coverage:

11 Dec 2017

Earnings vs. Estimates